October 28, 2015 / 6:33 AM / in 2 years

BRIEF-Pharming Group 9M net loss narrows to 5.9 mln euros

Oct 28 (Reuters) - Pharming Group NV :

* Reports Q3 revenue of 3.3 million euros ($3.6 million) versus 1.3 million euros previous year

* Q3 operating loss is 3.0 million euros versus a loss of 4.3 million euros a year ago

* Net loss decreased by 13.0 million euros to 5.9 million euros in first nine months of 2015 (first nine months 2014: 18.9 million euros)

* Total cash and cash equivalents (including restricted cash) increased by 0.7 million euros from 34.4 million euros at end of 2014 to 35.1 million euros at end of September 2015

* No financial guidance for 2015 is provided

Source text for Eikon: Further company coverage: ($1 = 0.9064 euros) (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below